Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201305133 Principal Investigator: Adkins, Douglas
Title: A Phase 1b, open-label, multi-center, dose escalation study of the safety, tolerability, pharmacodynamic and pharmacokinetic properties of intravenous GC4419 in combination with radiation and chemotherapy for squamous cell cancers of the head and neck
Phase: I Disease Site: Multiple Sites
Participating Site(s):
 
Main Campus
Map and Directions
South County
Map and Directions
St. Peters
Map and Directions
West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this study is to find out if an investigational drug called GC4419 can be used to prevent or decrease mouth pain and ulcers, which may be caused by cancer treatment.
 
More Information:
ClinicalTrials.Gov Link
Internal Protocol Documents (requires Siteman administrative database password)